We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China: ‘Equivalent’ Devices Can Bypass Clinical Trial Requirement
China: ‘Equivalent’ Devices Can Bypass Clinical Trial Requirement
Sponsors of Class II and Class III medical devices in China may bypass the need for clinical trials if they can show that the product is equivalent to a product listed in the country, new guidance says.